Unrelated transplants for poor prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact hematopoietic graft source Ferrá C, Sanz J, De la Cámara R, Sanz G, Bermúdez A, Valcárcel D, Rovira M, Serrano D, Caballero D, Espigado L, Morgades M, Heras I, Solano C, Duarte R, Barrenetxea C, García-Noblejas A, Díez-Martín JL, Iriondo A, Carreras E, Sierra J, Sanz MA, Ribera JM. Biology of Blood and Marrow 16(7):957-66. FI: 3.149 (Q2) Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia Peñalver FJ, Alvarez-Larrán A, Díez-Martín JL, Gallur L, Jarque I, Caballero D, Díaz-Mediavilla J, Bustelos R, Fernández-Aceñero MJ, Cabrera JR, Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA. Annals of Hematology 89(11):1073-80. FI: 2.919 (Q2) Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin¿s lymphoma patients at high risk of central nervous system disease in the rituximab era Sancho JM, Orfao A, Quijano S, García O, Panizo C, Pérez-Ceballos E, Deben G, Salar A, González-Barca E, Alonso N, García-Vela JA, Capote J, Peñalver FJ, Provencio M, Arias J, Plaza J, Caballero D, Morado M, Feliu E, Ribera JM, Spanish Group for the Study of CNS Disease in NHL. European Journal of Haematology 85(4):321-8. FI: 2.345 (Q3) Immunomodulatory effect of 5-azacytidine(5-azaC): potential role in the transplantation setting Sánchez-Abarca LI, Gutiérrez-Cosio S, Santamaría C, Caballero-Velázquez T, Blanco B, Herrero-Sánchez C, García JL, Carrancio S, Hernández-Campo P, González FJ, Flores T, Ciudad L, Ballestar E, Del Cañizo C, San Miguel JF, Pérez-Simón JA. Blood 115(1):107-21. FI: 10.555 (Q1) The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin¿s lymphoma García-Sanz R, González-López TJ, Vázquez L, Hermida G, Graciani IF, San Miguel JF. European Journal of Haematology 84(3):266-70. FI: 2.345 (Q3) Isolation and characterization of mesenchymal stromal cells from human degenerated nucleus pulposus: comparison with bone marrow mesenchymal stromal cells from the same subjects Blanco JF, Graciani IF, Sánchez-Guijo FM, Muntión S, Hernández-Campo P, Santamaría C, Carrancio S, Barbado MV, Cruz G, Gutiérrez-Cosío S, Herrero C, San Miguel JF, Briñón JG, Del Cañizo MC. Spine (Philadelphia PA 1976) 35(26):2259-65. FI: 2624.000 (Q2) Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells Pérez-Persona E, Mateo G, García-Sanz R, Mateos MV, de Las Heras N, de Coca AG, Hernández JM, Galende J, Martín-Nuñez G, Bárez A, Alonso JM, Martín A, López-Berges C, Orfao A, San Miguel JF, Vidriales MB. British Journal of Haematology 148(1):110-4. FI: 4.597 (Q1) Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial Mateos MV, Oriol A, Martínez-López J, Gutiérrez N, Teruel AI, de Paz R, García-Laraña J, Bengoechea E, Martín A, Mediavilla JD, Palomera L, de Arriba F, González Y, Hernández JM, Sureda A, Bello JL, Bargay J, Peñalver FJ, Ribera JM, Martín-Mateos ML, García-Sanz R, Cibeira MT, Ramos ML, Vidriales MB, Paiva B, Montalbán MA, Lahuerta JJ, Bladé J, Miguel JF. Lancet Oncology 11(10):934-41. FI: 14.470 (Q1) Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: influence of stem cell source Gallardo D, Perez-Garcia A, de la Camara R, Iriondo A, Jimenez-Velasco A, Torres A, Brunet S, Urbano-Ispizua A, Vallejo C, Encuentra M, Caballero D, Espigado I, Serrano D, Barrenetxea C, Ribera JM, de la Rubia J. Leukemia 20(8):1461-4. FI: 8.296 (Q1) Infectious/non-infectious complications subcommittee of the Grupo Español de Trasplante Hematopoyético (GETH). Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation Parody R, Martino R, Rovira M, Vázquez L, Vázquez MJ, de la Cámara R, Blázquez C, Fernández-Avilés F, Carreras E, Salavert M, Jarque I, Martín C, Martínez F, López J, Torres A, Sierra J, Sanz GF, Infectious/non-infectious complications subcommittee of the Grupo Español de Trasplante Hematopoyético (GETH). Biology of Blood and Marrow 12(7):734-48. FI: 3.149 (Q2)
|
